EPIX
ESSA Pharma Inc.
0.20
undefined x undefined
undefined x undefined
bid
ask
+
0.20
0.00%
07:00 PM
timesize
Ytd
1y
day range
52 week range
OpenPrev CloseLowHighMkt CapN/A
Vol0.00Avg Vol0.00EPSN/AP/EN/AForward P/E-3.26
Beta1.84Short Ratio0.32Inst. Own81.19%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est9.19
Income Statement
Operating Expenses4.90M
Research and Development Expense-531.44K
Selling, General and Administrative Expense5.43M
Operating Income-4.90M
Net Income-4.00M
Net Income Common Stock-4.00M
Net Income Common Stock (USD)-4.00M
Consolidated Income-4.00M
Earnings per Basic Share-0.09
Earnings per Basic Share (USD)-0.09
Earnings per Diluted Share-0.09
Earning Before Interest & Taxes (EBIT)-4.00M
Earning Before Interest & Taxes (USD)-4.00M
Weighted Average Shares44.39M
Weighted Average Shares Diluted44.39M
Balance Sheet
Cash and Equivalents85.95M
Cash and Equivalents (USD)85.95M
Investments23.67M
Investments Current23.67M
Trade and Non-Trade Receivables527.15K
Current Assets110.50M
Total Assets110.50M
Current Liabilities1.60M
Total Liabilities1.60M
Accumulated Retained Earnings (Deficit)-226.91M
Accumulated Other Comprehensive Income-2.10M
Shareholders Equity108.90M
Shareholders Equity (USD)108.90M
Trade and Non-Trade Payables1.60M
Cash Flow
Depreciation, Amortization & Accretion16.38K
Net Cash Flow / Change in Cash & Cash Equivalents-355.76K
Net Cash Flow from Investing3.84M
Net Cash Flow - Investment Acquisitions and Disposals3.84M
Net Cash Flow from Operations-4.20M
Share Based Compensation-633.93K